Main > RHEUMATOLOGY>RHEUMATOID ARTHRITIS > Treatment > p38 MAP Kinase Inhibitor Program > Compound (Co.: USA. Arq.) > Status (11.03)
Status (11.03)'s subsections
GLP Toxicology Studies
PreClinical Testing
Status (11.03)'s products
This section has no products